In this weeks episode we learn that not only does James Bond have amazing espionage skills but also an impenetrable immune system.    Tom celebrates the Phase II//III results for antiviral drug "Paxlovid" against SARS-COV-2 and dives into the events at COP26 while Evan evaluates the controversial approval of a new Alzheimer's drug, Aducanumab, and examines what the clinical trial results actually said.